Show Nav →
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
PLIN3 M6PRBP1, TIP47
Sequence Length (AA) Molecular Weight (Da)
434 47075
Protein Name
Perilipin-3
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MSADGAEADG STQVTVEEPV QQPSVVDRVA SMPLISSTCD MVSAAYASTK
60 70 80 90 100
ESYPHIKTVC DAAEKGVRTL TAAAVSGAQP ILSKLEPQIA SASEYAHRGL
110 120 130 140 150
DKLEENLPIL QQPTEKVLAD TKELVSSKVS GAQEMVSSAK DTVATQLSEA
160 170 180 190 200
VDATRGAVQS GVDKTKSVVT GGVQSVMGSR LGQMVLSGVD TVLGKSEEWA
210 220 230 240 250
DNHLPLTDAE LARIATSLDG FDVASVQQQR QEQSYFVRLG SLSERLRQHA
260 270 280 290 300
YEHSLGKLRA TKQRAQEALL QLSQVLSLME TVKQGVDQKL VEGQEKLHQM
310 320 330 340 350
WLSWNQKQLQ GPEKEPPKPE QVESRALTMF RDIAQQLQAT CTSLGSSIQG
360 370 380 390 400
LPTNVKDQVQ QARRQVEDLQ ATFSSIHSFQ DLSSSILAQS RERVASAREA
410 420 430 434
LDHMVEYVAQ NTPVTWLVGP FAPGITEKAP EEKK

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-112 Collapse assay details

Data source: Panorama

Official Gene Symbol
PLIN3
Peptide Sequence
IATSLDGFDVASVQQQR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
214
Peptide End
230
CPTAC ID
CPTAC-112
Peptide Molecular Mass
1,833.9221
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
cell line lysate pool
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Kennedy JJ, Abbatiello SE, Kim K, Yan P, Whiteaker JR, Lin C, Kim JS, Zhang Y, Wang X, Ivey RG, Zhao L, Min H, Lee Y, Yu MH, Yang EG, Lee C, Wang P, Rodriguez H, Kim Y, Carr SA, Paulovich AG. Nat Methods. 2014 Feb;11(2):149-55. doi: 10.1038/nmeth.2763. Epub 2013 Dec 8. PMID: 24317253


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
5500 QTRAP (ABSCIEX)
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C,15N
LC
nanoLC-Ultra 2D, cHiPLC-nanoflex (Eksigent)
Column Packing
ChromXP C18-CL, 3 um, 120A
Column Dimensions
150 x 0.075 mm
Flow Rate
500 nL / min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y11 (1+) 15.3 10.9 9.1 21.4 12.9 10.3 26.3 16.9 13.7 15 25 15
y9 (1+) 20.3 8 11.6 33.7 12.6 11.4 39.3 14.9 16.3 15 25 15
y7 (1+) 16.6 12.8 8.7 26.3 13.5 10 31.1 18.6 13.3 15 25 15
sum 12.6 9.4 7.6 22.5 11.1 7.3 25.8 14.5 10.5 15 25 15

Selectivity

Data source: Panorama

Slope of Curve Fit for cell line
fragment_ion HCC1187 HCC1419 HCC1954 HCC70 MCF12A MDAMB175VII ZR751 ZR7530
y11 (1+) -0.42 -0.08 -0.06 -0.18 -0.37 -0.23 -0.15 -0.03
y7 (1+) -0.37 -0.03 -0.08 -0.19 -0.21 -0.21 -0.28 -0.03
y9 (1+) -0.31 -0.08 -0.1 -0.12 -0.28 -0.16 -0.19 -0.04
sum -0.37 -0.06 -0.08 -0.17 -0.27 -0.2 -0.22 -0.03

Stability

Data source: Panorama

Fragment ion / Transition control_intra_CV actual_temp_intra_CV frozen_intra_CV FTx1_intra_CV FTx2_intra_CV
y7 (1+) 10 11.4 5.4 NA 16.8
y9 (1+) 4.6 3.9 4.2 NA 8.3
y11 (1+) 9.5 3.5 6 NA 14.6
sum 7.2 6 1.8 NA 13.8
Fragment ion / Transition all_intra_CV all_inter_CV
y7 (1+) 11 10.4
y9 (1+) 5 4.7
y11 (1+) 7.4 8.5
sum 6.9 7.1

Endogenous

Data source: Panorama

Fragment ion / Transition intra_CV inter_CV total_CV
y7 (1+) 12.6 13.3 18.3
y9 (1+) 8 11.6 14.1
y11 (1+) 10.8 12.9 16.8
sum 9.4 11.1 14.5

Additional Resources and Comments


Assay Details for CPTAC-111 Collapse assay details

Data source: Panorama

Official Gene Symbol
PLIN3
Peptide Sequence
TLTAAAVSGAQPILSK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
69
Peptide End
84
CPTAC ID
CPTAC-111
Peptide Molecular Mass
1,526.8668
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
cell line lysate pool
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Kennedy JJ, Abbatiello SE, Kim K, Yan P, Whiteaker JR, Lin C, Kim JS, Zhang Y, Wang X, Ivey RG, Zhao L, Min H, Lee Y, Yu MH, Yang EG, Lee C, Wang P, Rodriguez H, Kim Y, Carr SA, Paulovich AG. Nat Methods. 2014 Feb;11(2):149-55. doi: 10.1038/nmeth.2763. Epub 2013 Dec 8. PMID: 24317253


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
5500 QTRAP (ABSCIEX)
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C,15N
LC
nanoLC-Ultra 2D, cHiPLC-nanoflex (Eksigent)
Column Packing
ChromXP C18-CL, 3 um, 120A
Column Dimensions
150 x 0.075 mm
Flow Rate
500 nL / min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y10 (1+) 12.8 6.4 6 15.6 6.6 9.5 20.2 9.2 11.2 15 25 15
y9 (1+) 9.1 5.9 5 9.4 7.5 7.9 13.1 9.5 9.3 15 25 15
y8 (1+) 16.6 7.1 7.1 16.7 7.3 6.4 23.5 10.2 9.6 15 25 15
sum 8.6 5.4 4.7 9.9 6.1 6.2 13.1 8.1 7.8 15 25 15


Stability

Data source: Panorama

Fragment ion / Transition control_intra_CV actual_temp_intra_CV frozen_intra_CV FTx1_intra_CV FTx2_intra_CV
Fragment ion / Transition all_intra_CV all_inter_CV

Additional Resources and Comments


Assay Details for non-CPTAC-3862 Collapse assay details

Data source: Panorama

Official Gene Symbol
Plin3
Peptide Sequence
LEPQIATASEYAHR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
85
Peptide End
98
CPTAC ID
non-CPTAC-3862
Peptide Molecular Mass
1,584.7896
Species
Mus musculus (Mouse)
Assay Type
Direct MRM
Matrix
Plasma
Submitting Laboratory
UVic-Genome BC Proteomics Centre
Submitting Lab PI
Christoph Borchers

Publication

View Details (opens in a new window)

Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays. Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y Eshghi A1, Richard VR, Sickmann A, Borchers CH. Commun Biol. 2018 Jun 27;1:78. doi: 10.1038/s42003-018-0087-6. eCollection 2018.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Agilent 6490/6495 QQQ
Internal Standard
synthetic peptide
Peptide Standard Purity
>80%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
1290 LC (Agilent)
Column Packing
Zorbax Eclipse Plus C18, 1.8 µm
Column Dimensions
2.1 x 150 mm
Flow Rate
400 µL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
b2 (1+) 10.2 3.4 4.4 8.8 10.3 5.2 13.5 10.8 6.8 15 15 15
y12 (3+) 7.7 6 4.7 13.5 7.7 5.9 15.5 9.8 7.5 15 15 15
y12 (2+) 8.9 3.3 4.1 8.7 6.7 6.5 12.4 7.5 7.7 15 15 15
y3 (1+) 31.6 14.3 8.3 35.4 11.7 8.2 47.5 18.5 11.7 15 15 15
y4 (1+) 10.7 10.3 4.9 31.8 12 8.7 33.6 15.8 10 15 15 15
sum 5.8 3.2 2.2 6.2 6.3 4.9 8.5 7.1 5.4 15 15 15


Additional Resources and Comments